[go: up one dir, main page]

HRP20020154B1 - Pharmaceutical compositions for oral and topical administration - Google Patents

Pharmaceutical compositions for oral and topical administration

Info

Publication number
HRP20020154B1
HRP20020154B1 HR20020154A HRP20020154A HRP20020154B1 HR P20020154 B1 HRP20020154 B1 HR P20020154B1 HR 20020154 A HR20020154 A HR 20020154A HR P20020154 A HRP20020154 A HR P20020154A HR P20020154 B1 HRP20020154 B1 HR P20020154B1
Authority
HR
Croatia
Prior art keywords
oral
ch2or
chor
ch2o
topical administration
Prior art date
Application number
HR20020154A
Other languages
English (en)
Croatian (hr)
Inventor
Andrysek Tomas
Stuchlik Milan
Vrana Ales
Jegorov Alexandr
Stuchlik Josef
Matha Vladimir
Original Assignee
Ivax Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10859192&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20020154(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ivax Pharmaceuticals filed Critical Ivax Pharmaceuticals
Publication of HRP20020154A2 publication Critical patent/HRP20020154A2/hr
Publication of HRP20020154B1 publication Critical patent/HRP20020154B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
HR20020154A 1999-08-17 2000-08-17 Pharmaceutical compositions for oral and topical administration HRP20020154B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9919288A GB2355656B (en) 1999-08-17 1999-08-17 Pharmaceutical compositions for oral and topical administration
PCT/GB2000/003161 WO2001012229A1 (en) 1999-08-17 2000-08-17 Pharmaceutical compositions for oral and topical administration

Publications (2)

Publication Number Publication Date
HRP20020154A2 HRP20020154A2 (en) 2003-12-31
HRP20020154B1 true HRP20020154B1 (en) 2006-07-31

Family

ID=10859192

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020154A HRP20020154B1 (en) 1999-08-17 2000-08-17 Pharmaceutical compositions for oral and topical administration

Country Status (40)

Country Link
US (1) US20070190132A1 (es)
EP (2) EP1210119B1 (es)
JP (2) JP2003507343A (es)
KR (2) KR100828747B1 (es)
CN (2) CN1382061A (es)
AR (2) AR025324A1 (es)
AT (2) ATE402691T1 (es)
AU (1) AU777740B2 (es)
BR (1) BR0013385A (es)
CA (2) CA2380951C (es)
CO (1) CO5380014A1 (es)
CY (1) CY1105318T1 (es)
CZ (2) CZ296591B6 (es)
DE (2) DE60018081T2 (es)
DK (2) DK1334717T3 (es)
EE (2) EE04955B1 (es)
EG (1) EG23994A (es)
ES (2) ES2237443T3 (es)
GB (1) GB2355656B (es)
HK (1) HK1049629A1 (es)
HR (1) HRP20020154B1 (es)
HU (1) HUP0203236A3 (es)
IL (4) IL158108A0 (es)
JO (1) JO2324B1 (es)
MX (1) MXPA02001631A (es)
NO (2) NO20020760L (es)
NZ (1) NZ517271A (es)
PE (1) PE20010636A1 (es)
PL (1) PL192769B1 (es)
PT (2) PT1210119E (es)
RU (2) RU2279894C2 (es)
SA (1) SA00210487B1 (es)
SG (1) SG143019A1 (es)
SI (1) SI1210119T1 (es)
SK (2) SK2482002A3 (es)
TN (1) TNSN00173A1 (es)
UA (2) UA72539C2 (es)
UY (1) UY26303A1 (es)
WO (1) WO2001012229A1 (es)
ZA (2) ZA200308221B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration
FR2826261B1 (fr) * 2001-06-26 2005-03-25 Lmd Composition a usage topique comprenant un produit cytotoxique et son utilisation dans le traitement de l'alopeche
DE10154464B4 (de) * 2001-11-08 2005-10-20 Max Delbrueck Centrum Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol
KR20030065831A (ko) * 2002-02-01 2003-08-09 주식회사 태평양 사이클로스포린을 함유한 지속 방출형 약학적 조성물
US9101540B2 (en) 2002-04-12 2015-08-11 Alkermes Pharma Ireland Limited Nanoparticulate megestrol formulations
US7101576B2 (en) * 2002-04-12 2006-09-05 Elan Pharma International Limited Nanoparticulate megestrol formulations
EP1935407A1 (en) * 2002-12-03 2008-06-25 Elan Pharma International Limited Low viscosity liquid dosage forms
JP4518042B2 (ja) * 2002-12-04 2010-08-04 日油株式会社 コエンザイムｑ１０を含有する水溶性組成物の製造方法
US7470436B2 (en) 2002-12-04 2008-12-30 Nisshin Pharma Inc. Water-soluble composition containing coenzyme Q10
EP3470084A1 (en) 2002-12-09 2019-04-17 Abraxis BioScience, LLC Compositions and methods of delivery of pharmacological agents
US6979672B2 (en) * 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules
EP1806125B1 (en) * 2004-10-20 2011-08-03 Kao Corporation Liquid compositions for oral cavity
EP1855659A2 (en) * 2005-02-24 2007-11-21 Elan Pharma International Limited Nanoparticulate formulations of docetaxel and analogues thereof
KR20110091862A (ko) * 2008-11-28 2011-08-16 어드밴스 홀딩스 리미티드 다이클로페낙과 하이드록시 지방산 폴리알킬렌 에스터를 포함하는 약학적 제제
DK2405892T3 (da) * 2009-03-12 2013-04-08 Advance Holdings Ltd Farmaceutisk formulering omfattende ketoprofen og en polyoxyalkylenester af en hydroxy-fedtsyre
KR101100933B1 (ko) * 2009-04-23 2012-01-02 한국기술교육대학교 산학협력단 솔더 볼 제거 장치
JP6763939B2 (ja) * 2015-03-27 2020-09-30 アーチ・パーソナル・ケア・プロダクツ・エルピー パーソナルケア製品のための粘度増強組成物
CN112426403B (zh) * 2020-12-09 2021-09-17 南京天纵易康生物科技股份有限公司 一种口腔溃疡凝胶及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
CZ288631B6 (cs) * 1996-01-18 2001-08-15 Galena, A. S. Léčivé přípravky s obsahem cyklosporinu
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky
CZ267796A3 (cs) * 1996-09-12 1998-04-15 Galena A.S. Léčivé přípravky, zejména pro vnitřní aplikaci, ve formě samomikroemulgujících terapeutických systémů
EP0973502A1 (en) * 1997-03-12 2000-01-26 Abbott Laboratories Lipophilic binary systems for the administration of lipophilic compounds
NZ337316A (en) * 1997-03-12 2001-06-29 Abbott Lab Hydrophilic binary systems comprising cyclosporine, hydrophilic phase and a surfactant for the administration of cyclosporine
CZ297206B6 (cs) * 1997-07-29 2006-10-11 Pharmacia & Upjohn Company Farmaceutická kompozice a samoemulgující formulace pro lipofilní slouceniny
US6063762A (en) * 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
US20030216303A1 (en) * 1998-03-06 2003-11-20 Michael Ambuhl Emulsion preconcentrates containing cyclosporin or a macrolide
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration

Also Published As

Publication number Publication date
ZA200201315B (en) 2004-06-30
EP1210119B1 (en) 2005-02-09
DE60018081T2 (de) 2006-01-05
HRP20020154A2 (en) 2003-12-31
IL148200A0 (en) 2002-09-12
DE60018081D1 (de) 2005-03-17
PT1334717E (pt) 2008-10-09
NO20020760D0 (no) 2002-02-15
UA75926C2 (en) 2006-06-15
AR025324A1 (es) 2002-11-20
MXPA02001631A (es) 2003-07-14
PE20010636A1 (es) 2001-06-02
EE04954B1 (et) 2008-02-15
IL148200A (en) 2007-12-03
NO20020760L (no) 2002-04-16
CZ296591B6 (cs) 2006-04-12
EE200200075A (et) 2003-04-15
JO2324B1 (en) 2005-09-12
RU2279895C2 (ru) 2006-07-20
EP1210119A1 (en) 2002-06-05
CY1105318T1 (el) 2010-03-03
UY26303A1 (es) 2001-03-16
PT1210119E (pt) 2005-05-31
CN1382061A (zh) 2002-11-27
HK1049629A1 (zh) 2003-05-23
WO2001012229A1 (en) 2001-02-22
AU777740B2 (en) 2004-10-28
CA2380951C (en) 2010-03-23
DK1334717T3 (da) 2008-11-24
KR20050095651A (ko) 2005-09-29
SI1210119T1 (en) 2005-06-30
US20070190132A1 (en) 2007-08-16
EG23994A (en) 2008-03-10
SA00210487B1 (ar) 2006-09-10
HUP0203236A2 (hu) 2003-01-28
ZA200308221B (en) 2004-09-29
ATE288766T1 (de) 2005-02-15
PL353445A1 (en) 2003-11-17
UA72539C2 (en) 2005-03-15
AR043106A2 (es) 2005-07-20
AU6461300A (en) 2001-03-13
SG143019A1 (en) 2008-06-27
DE60322454D1 (de) 2008-09-11
SK286083B6 (sk) 2008-03-05
EP1334717A3 (en) 2004-01-02
KR100828748B1 (ko) 2008-05-09
JP2004238399A (ja) 2004-08-26
CZ296170B6 (cs) 2006-01-11
ES2237443T3 (es) 2005-08-01
EP1334717A2 (en) 2003-08-13
TNSN00173A1 (en) 2005-11-10
KR100828747B1 (ko) 2008-05-09
NO20034778L (no) 2002-04-16
PL192769B1 (pl) 2006-12-29
RU2279894C2 (ru) 2006-07-20
DK1210119T3 (da) 2005-06-20
ES2311077T3 (es) 2009-02-01
EE04955B1 (et) 2008-02-15
JP2003507343A (ja) 2003-02-25
EE200300371A (et) 2003-10-15
CA2380951A1 (en) 2001-02-22
SK2482002A3 (en) 2002-12-03
NZ517271A (en) 2004-02-27
CZ2002575A3 (cs) 2003-05-14
GB2355656A (en) 2001-05-02
RU2003133451A (ru) 2005-04-20
BR0013385A (pt) 2002-05-07
HUP0203236A3 (en) 2004-06-28
ATE402691T1 (de) 2008-08-15
KR20020059367A (ko) 2002-07-12
CA2452118A1 (en) 2001-02-22
CN101406453A (zh) 2009-04-15
NO20034778D0 (no) 2003-10-24
EP1334717B1 (en) 2008-07-30
IL158108A0 (en) 2004-03-28
GB9919288D0 (en) 1999-10-20
CO5380014A1 (es) 2004-03-31
GB2355656B (en) 2004-04-07
IL158108A (en) 2010-04-15

Similar Documents

Publication Publication Date Title
HRP20020154B1 (en) Pharmaceutical compositions for oral and topical administration
DE69901951D1 (de) Verwendung gelierbarer pharmazeutischer zusammensetzungen in der parodontologie
KR890001521A (ko) 서방형 신규 제약 제제물
ATE279209T1 (de) Injizierbare pharmazeutische zusammensetzung zur systemischen verabreichung pharmakologisch aktiver wirkstoffe enthaltend mittelkettige triglyceride
PL177592B1 (pl) Kompozycja farmaceutyczna lub weterynaryjna w postaci kremu
DK0904064T3 (da) Orale farmaceutiske præparater indeholdende kønshormoner
CA1294555C (en) Skin tanning agent
JPS5663923A (en) Suppository base composition
FR2800608B1 (fr) Composition cosmetique contenant un ester d'acide gras hydroxyle
SK279411B6 (sk) Transparentné lipogélové zmesi a spôsob ich prípra
RU2002106825A (ru) Фармацевтические композиции для перорального и местного применения
KR880007069A (ko) 트리글리세라이드 조성물
UA90253C2 (ru) Нетаблетированные жевательные дозировочные формы для индивидуального введения
ES8400028A1 (es) Metodo de preparacion de una composicion tixotropica anhidra.
JP4722351B2 (ja) 酸化的に安定な長鎖エチルエステル皮膚軟化薬
JPS5632408A (en) Cosmetic
IT1204778B (it) Formulazioni farmaceutiche iniettabili di principi attivi ad attivita' anestetica generale
RU99121398A (ru) Фармацевтические композиции
JPS57165305A (en) Method of increasing the potency of bactericidal disinfectant of surface active agent
UY28008A1 (es) Composiciones farmacéuticas para administración oral y tópica
CO4940404A1 (es) Composiciones farmaceuticas
CZ282830B6 (cs) Léčivá mast bez dráždivého účinku na kůži a způsob její přípravy
ES8601692A1 (es) Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo
JPS5611953A (en) Air-treating agent containing gel composition
CS238789B1 (cs) Kapalné přípravky s liposolubilnimi vitaminy

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: IVAX PHARMACEUTICALS, S.R.O., CZ

B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20090814

Year of fee payment: 10

PBON Lapse due to non-payment of renewal fee

Effective date: 20100818